fbpx

News Theme: Science

Companies move into the newly refurbished Hayakawa Building at The Oxford Science Park
Real Estate

Companies move into refurbished Hayakawa Building at The Oxford Science Park

New occupiers, CyanoCapture and Ochre Bio, are joining MiroBio, MoA Technology and Oxford Nanopore Technologies, who are expanding their footprint on the Park, as well as Circassia, which is relocating from another building.
UK’s Vaccines Manufacturing Innovation Centre (VMIC) bought by USA’s Catalent
Real Estate

UK’s Vaccines Manufacturing Innovation Centre (VMIC) bought by USA’s Catalent

Catalent plans to invest up to £120 million to complete the building of the facility and equip it with “state-of-the-art capabilities, but many have called the sale by the UK Government ‘short-sighted’.
Oxford University develops test that can identify cancer and if it has spread
Life Sciences

Oxford Uni develops test that can identify cancer and if it has spread

The study analysed samples from 300 patients with non-specific but concerning symptoms of cancer, and their results show that cancer was correctly detected in 19 out of every 20 patients with cancer using this test.
Oxford team publish blueprint for making millions of doses of a new vaccine within 100 days
Life Sciences

Oxford team publish blueprint for making millions of doses of new vaccine

The researchers believe their work could help compress vaccine development timelines to 100 days from pathogen identification to mass production and distribution.
Nine businesses take space in The Oxford Trust’s two innovation centres
Real Estate

Nine businesses take space in The Oxford Trust’s innovation centres

The early-stage science and technology start-up businesses have taken space, as Oxford continues to see strong demand from businesses needing R&D labs, technical workspace and flexible office space.
Antibody by llamas has ‘significant potential’ as COVID-19 treatment
Life Sciences

Antibody by llamas has ‘significant potential’ as COVID-19 treatment

The research, by scientists at the Rosalind Franklin Institute, has shown that nanobodies generated by llamas and camels can effectively target the SARS-CoV-2 virus that causes COVID-19.
Further government funding for phase II R&D lab conversion at Wood Centre for Innovation. Image: Phase 1 converted labs at Wood Centre for Innovation
Life Sciences

Further funding for phase II R&D lab conversion at Wood Centre for Innovation

The funding will allow The Oxford Trust to commence the conversion of dedicated high spec laboratory facilities with 3,000 sq ft of laboratory and close to 9,000 sq ft of allied space.
Study finds COVID-19 presents a higher risk of blood clots than vaccines
Life Sciences

Study finds COVID-19 presents higher risks of blood clots than vaccines

The study concludes that there are increased risks of some haematological and vascular adverse events following vaccination, but the risks are substantially higher following a coronavirus infection.
AI imaging solutions company Ultromics raises $33m in Series B funding
Life Sciences

AI imaging solutions company Ultromics raises $33m in Series B funding

Led by Blue Venture Fund, the new funding will accelerate Oxford-based Ultromics’ use of AI-enabled echocardiograms to improve patient outcomes.
PepGen secures $112.5m financing to advance muscular dystrophy therapies
Life Sciences

PepGen secures $112.5m financing to advance muscular dystrophy therapies

The funding round included existing investors RA Capital Management, Oxford Sciences Innovation (OSI) and CureDuchenne Ventures and a host of new investors.